Genetics: Clinical exome sequencing in neurology practice

Area of Science:

• Genetics
• Neurology
• Molecular Diagnostics

Background:

• Clinical exome sequencing (CES) is increasingly adopted for diagnosing genetic disorders.
• CES has demonstrated a diagnostic yield of approximately 25% in various patient populations.

Purpose of the Study:

• To evaluate the diagnostic yield of CES in neurogenetic disorders.
• To assess the utility of CES for both early-onset and adult-onset neurological conditions.
• To delineate the strengths, limitations, and future potential of CES in clinical neurology.

Main Methods:

• Review of recent studies on clinical exome sequencing in neurology.
• Analysis of diagnostic yield data for neurogenetic disorders.
• Assessment of CES performance across different age groups and diseaseOnsets.

Main Results:

• CES shows a favorable diagnostic yield for neurogenetic disorders.
• The diagnostic utility of CES is confirmed for both early-onset and adult-onset conditions.
• Key strengths and limitations of CES in neurological practice have been identified.

Conclusions:

• Clinical exome sequencing is a valuable tool for the molecular diagnosis of neurogenetic disorders.
• CES offers significant potential for improving diagnostic outcomes in neurology.
• Further research is warranted to optimize the application and interpretation of CES in clinical practice.